N-(biphenyl-4-ylmethyl)-5-hydroxy-2-methyl-4-thioxo-4H-pyran-3-carboxamide

ID: ALA498272

Chembl Id: CHEMBL498272

PubChem CID: 16726064

Max Phase: Preclinical

Molecular Formula: C20H17NO3S

Molecular Weight: 351.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1occ(O)c(=S)c1C(=O)NCc1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C20H17NO3S/c1-13-18(19(25)17(22)12-24-13)20(23)21-11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,12,22H,11H2,1H3,(H,21,23)

Standard InChI Key:  NSHZQFVEIUWJLE-UHFFFAOYSA-N

Associated Targets(Human)

MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.43Molecular Weight (Monoisotopic): 351.0929AlogP: 4.62#Rotatable Bonds: 4
Polar Surface Area: 62.47Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.48CX Basic pKa: CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -0.58

References

1. Yan YL, Miller MT, Cao Y, Cohen SM..  (2009)  Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.,  19  (7): [PMID:19261472] [10.1016/j.bmcl.2009.02.044]
2. Arshad JZ, Hanif M..  (2022)  Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.,  13  (10.0): [PMID:36325396] [10.1039/d2md00175f]

Source